| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 0.867 | 14 | 1 | 1992 | 2017 | ||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1992 | 2019 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 1993 | 2019 | ||||||||
|
biglycan | 0.484 | 0.808 | 0.45 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.040 | None | 1.000 | 3 | 3 | 1998 | 2017 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2017 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2000 | 2019 | ||||||||
|
serpin family H member 1 | 0.545 | 0.769 | 2.8E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 1 | 0.460 | 0.885 | 6.2E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
matrix metallopeptidase 13 | 0.452 | 0.923 | 7.9E-18 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2018 | ||||||||
|
transforming growth factor beta induced | 0.484 | 0.769 | 6.0E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
galactosidase beta 1 | 0.448 | 0.808 | 7.9E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2008 | ||||||||
|
tenascin C | 0.433 | 0.846 | 1.3E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2006 | 2019 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2015 | ||||||||
|
SMAD family member 2 | 0.456 | 0.808 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2016 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
metallothionein 1A | 0.537 | 0.808 | 4.5E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2008 | 2010 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2009 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2019 |